Gent, Belgium, June 23, 2023

Aphea.Bio, a leading agricultural technology company, is proud to announce it is now a Certified B Corporation (B Corp). The prestigious certification reflects Aphea.Bio's commitment to meet high social and environmental impact, accountability, and transparency.

To become a Certified B Corporation, businesses undergo a rigorous and extensive assessment to evaluate their impact on their workers, customers, communities, governance, and the environment.

Aphea.Bio has achieved an outstanding score of 94.5, well above the minimum verified score of 80 required for certification.

"We're on a mission to deliver novel, science-based solutions that contribute to a sustainable, equitable and reliable agriculture. Our B Corp Certification reflects our commitment to achieving this goal in the most sustainable and responsible manner, always remaining accountable to people and the planet. We are incredibly honoured to join a global community of like-minded organizations that, like us, believe in conducting business as a force for good," said Inge Van Daele, Portfolio and ESG Manager at Aphea.Bio.

"Making a positive impact on today's agriculture is high on our agenda," said Isabel Vercauteren, CEO at Aphea.Bio. Supported by our shareholders we are working towards a more sustainable planet and the B Corp Certification is a great recognition of our efforts.

"As an impact investor, it is core to our value-add to support our companies through their ESG and impact journey. In our view, B Corp certification provides a rigorous framework to assess sustainability and also serves as a powerful guide to continuously integrate solid internal and external sustainable practices. We are glad to see Aphea.Bio reaching that milestone showcasing their commitment to both business success and positive impact, exemplifying their dedication to sustainability and social responsibility." Said Leslie Kapin, Impact and Sustainability Director at Astanor Ventures.

"Before investing in spring 2021, we conducted a thorough ESG due diligence on Aphea.Bio, which we completed with excellent results. Ever since, our initial positive impression has been confirmed in day-to-day business. Aphea.Bio can easily meet the strongly increasing regulatory sustainability requirements due to its focus on sustainability. Therefore, we are delighted to be able to confirm the positive outcome of B Lab's assessment." Said Cornelia Frentz, ESG Manager, European Circular Bioeconomy Fund (ECBF).

Aphea.Bio proudly joins more than 6,900 companies across 90 countries committed to creating value for all stakeholders. The company is more than ever determined to live up to its ambition to deliver cutting-edge biological solutions that help farmers feed growing populations in a safe, healthy, and sustainable manner.

About Aphea.Bio

Aphea.Bio was founded by Isabel Vercauteren (now CEO of Aphea.Bio) and Steven Vandenabeele (now CTO of Aphea.Bio) on 5 December 2016 as a spin-off of the VIB (Flemish Institute for Biotechnology) and its partner universities Ghent University and KU Leuven, and is dedicated to food security and ensuring a safe and healthy food chain. We aim to provide novel, science-based solutions to build the agriculture of the future: sustainable, reliable and profitable. Located in Gent, Belgium, we have a highly dedicated and qualified team of scientist and industry experts. Based on our unique high throughput R&D platform utilizing the untapped microbial space, we have been able to build a broad biostimulant and biocontrol pipeline based on naturally occurring micro-organisms.

We believe that with a fresh and sincere spirit of innovation, result-driven science, and the courage to go off the beaten track, there is fertile ground to develop efficacious biological solutions to help complement or partially replace products in the major chemical indications. To learn more, visit www.aphea.bio or follow us on LinkedIn at www.linkedin.com/company/aphea-bio.

Aphea Bio Charlotte Klank Head of Regulatory Affairs | Communications [email protected]

Data protection is important to us. You are receiving this publication on the legal basis of Article 6 para 1 lit. f GDPR ("legitimate interest"). However, if you do not wish to receive further information about Aphea.Bio, just send us a brief informal message and we will no longer process your details for this purpose. You can also find further details in our privacy statement.

Cautionary Statement Regarding Forward-Looking Statements

This document may contain forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. For Aphea.Bio, such risks and uncertainties include risks relating to legal proceedings, regulatory approvals, new product development, increasing competition, customer credit risk, general economic and market conditions, compliance and remediation, intellectual property rights, implementation of organizational changes, impairment of intangible assets, consumer perceptions of genetically modified crops and organisms or crop protection chemicals, climatic variations, fluctuations in exchange rates and/or commodity prices, single source supply arrangements, political uncertainty, natural disasters, and breaches of data security or other disruptions of information technology. Aphea.Bio assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors.

© Aphea.Bio, Technologiepark Zwijnaarde 21, 9052 Zwijnaarde.

About Aphea.Bio

Aphea.Bio is a fully integrated microbial product development company dedicated to food security and ensuring a safe and healthy food chain and is providing novel, science-based solutions to build the agriculture of the future: sustainable, reliable, and profitable. Located in Gent, Belgium, we have a highly dedicated and qualified team of scientist and industry experts. Based on our unique high throughput APEX® R&D platform utilising the untapped microbial space, we have been able to build a broad biostimulant and biocontrol pipeline based on naturally occurring micro-organisms.

We believe that with a fresh and sincere spirit of innovation, result-driven science, and the courage to go off the beaten track, there is fertile ground to develop efficacious biological solutions to help complement or partially replace products in the major chemical indications.

To learn more, visit www.aphea.bio or follow us on LinkedIn at www.linkedin.com/company/aphea-bio.

Aphea Bio
Charlotte Klank
Head of Regulatory Affairs | Communications
[email protected]


Data protection is important to us. You are receiving this publication on the legal basis of Article 6 para 1 lit. f GDPR ("legitimate interest"). However, if you do not wish to receive further information about Aphea.Bio, just send us a brief informal message and we will no longer process your details for this purpose. You can also find further details in our privacy statement.

Cautionary Statement Regarding Forward-Looking Statements

This document may contain forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. For Aphea.Bio, such risks and uncertainties include risks relating to legal proceedings, regulatory approvals, new product development, increasing competition, customer credit risk, general economic and market conditions, compliance and remediation, intellectual property rights, implementation of organizational changes, impairment of intangible assets, consumer perceptions of genetically modified crops and organisms or crop protection chemicals, climatic variations, fluctuations in exchange rates and/or commodity prices, single source supply arrangements, political uncertainty, natural disasters, and breaches of data security or other disruptions of information technology. Aphea.Bio assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors.

© Aphea.Bio, Technologiepark Zwijnaarde 21, 9052 Zwijnaarde.